Found: 7
Select item for more details and to access through your institution.
The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease.
- Published in:
- 1999
- By:
- Publication type:
- journal article
The Alleged Transformation from Two-Field to Three-field Systems in Medieval England.
- Published in:
- Economic History Review, 1986, v. 39, n. 4, p. 526, doi. 10.2307/2596482
- By:
- Publication type:
- Article
The Chronology of Enclosure and Economic Development in Medieval Devon.
- Published in:
- Economic History Review, 1975, v. 28, n. 2, p. 181, doi. 10.2307/2593483
- By:
- Publication type:
- Article
Diversity in Medical Device Clinical Trials: Do We Know What Works for Which Patients?
- Published in:
- Milbank Quarterly, 2018, v. 96, n. 3, p. 499, doi. 10.1111/1468-0009.12344
- By:
- Publication type:
- Article
Does Decentralization Improve Health System Performance and Outcomes in Low‐ and Middle‐Income Countries? A Systematic Review of Evidence From Quantitative Studies.
- Published in:
- Milbank Quarterly, 2018, v. 96, n. 2, p. 323, doi. 10.1111/1468-0009.12327
- By:
- Publication type:
- Article
Longitudinal in vivo metabolic labeling reveals tissue-specific mitochondrial proteome turnover rates and proteins selectively altered by parkin deficiency.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38484-0
- By:
- Publication type:
- Article
Doctor - how quickly will my Parkinson's progress?
- Published in:
- 2015
- By:
- Publication type:
- Editorial